HIGHLIGHTS
- who: October and collaborators from the Kaohsiung Medical University, Taiwan have published the research work: In vitro effect of Withania somnifera , AYUSH-64, and remdesivir on the activity of CYP-450 enzymes: Implications for possible herb drug interactions in the management of COVID-19, in the Journal: (JOURNAL)
- what: In the present study, the I/Ki ratio of frontiersin.org 10.3389/fphar.2022.973768 Frontiers in Pharmacology frontiersin.org 10.3389/fphar.2022.973768 ketoconazole (CYP3A4 inhibitor) was 28.73, while for remdesivir it was 6.87, which showed moderate/weak inhibition of CYP3A4 . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.